Executive Profile

James E. Niedel M.D., Ph.D. Managing Director, New Leaf Venture Partners

Age	Total Calculated Compensation	This person is connected to 7 Board Members in 7 different organizations across 13 different industries. See Board Relationships
67	--

Background

Dr. James E. Niedel, Jim M.D., Ph.D., serves as Managing Director of New Leaf Venture Partners. Dr. Niedel founded New Leaf Venture Partners. Prior to this, he worked as a Venture Partner at Sprout Group, Sprout Capital X, L.P. and Sprout Capital IX, L.P. He joined Sprout Group on May 1, 2002 and focused on investments in healthcare technology. Prior to Sprout, he also served as the Chief Science and Technology Officer at GlaxoSmithKline plc and served as its Head of ... Research and Development. From 1988 to 1995, he served as a Vice President of Research and Senior Vice President for Research and Development at Glaxo Inc. He serves as Executive Chairman of Oriel Therapeutics, Inc. He served as Chairman of the Board at Chimerix, Inc. until February 2013. Dr. Niedel served as the Chairman of Sirna Therapeutics Inc. from April 2003 to March 1, 2006 and served as its Director since April 2003. He has been a Director of Chimerix, Inc since February 2011 and Tolerx, Inc., since December 2002. He serves as Director of Tioga Pharmaceuticals, Inc., Presidio Pharmaceuticals, Inc., Pearl Therapeutics Inc., and Intarcia Therapeutics, Inc. He serves as a Member of the Sceintific Advisory Board at Siena Biotech S.p.A. He served as Director of CRF Inc. (also known as CRF Box) since October 2001. He served as a Member of Scientific Advisory Board of Valeant Pharmaceuticals International since April 5, 2004 and a Director of CLOSURE Medical Corporation since October 2001. He served as a Director of Sopherion Therapeutics, LLC. He was a Member of the Board of Directors of Glaxo Wellcome PLC with responsibility for Global Research and Development, Information Technology, and Product Strategy. Before joining the pharmaceutical industry, he was a Professor of Medicine and the Chief of the division of Clinical Pharmacology at Duke Medical School, where he completed an Internal Medicine residency and a Hematology Oncology fellowship. He is a Searle Scholar and a Fellow of the Royal College of Physicians (London). Dr. Niedel received an M.D. and a Ph.D. in Biochemistry from the University of Miami. He also holds a B.S. in Psychology and Chemistry from the University of Wisconsin.

Corporate Headquarters 7 Times Square New York, New York 10036 United States Phone: 646-871-6400 Fax: 646-871-6450 Board Members Memberships Director Intarcia Therapeutics, Inc. Former Director Sopherion Therapeutics, LLC Executive Chairman Oriel Therapeutics, Inc. Director Tioga Pharmaceuticals, Inc. Former Director Presidio Pharmaceuticals, Inc. Director Pearl Therapeutics Inc. 2001-N/A Former Director and Member of Audit Committee CLOSURE Medical Corporation 2001-N/A Former Director CRF Inc. 2002-Present Director, Member of Nominating Committee and Member of Corporate Governance Committee Tolerx, Inc. 2003-N/A Former Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee Sirna Therapeutics Inc. 2011-Present Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee Chimerix, Inc. Education PhD University of Miami MD University of Miami BS Concordia University, Wisconsin Other Affiliations Sprout Group Intarcia Therapeutics, Inc. Sirna Therapeutics Inc. Valeant Pharmaceuticals International GlaxoSmithKline plc CLOSURE Medical Corporation CRF Inc. Tolerx, Inc. Sopherion Therapeutics, LLC Chimerix, Inc. Sprout Capital IX, L.P. University of Miami Concordia University, Wisconsin Siena Biotech S.p.A. Oriel Therapeutics, Inc. Tioga Pharmaceuticals, Inc. Duke Medical School Presidio Pharmaceuticals, Inc. Pearl Therapeutics Inc. Sprout Capital X, L.P.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.